Cetaphil Appears in 15.2% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending Sunscreen Brands. For more detail, you can also read Sunscreen Brands: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- Cetaphil appears in a modest share of benchmark answers, but most mentions are positive and include a recommendation.
- The main gap is reach and placement: the brand is named less often than leading competitors and rarely earns the top slot.
- No conflicting claims were recorded in the captured answers, so the first step is to maintain a scoped fact-review register.
- Recorded buyer questions center on sensitive-skin sunscreen needs, including mineral, non-comedogenic, avobenzone-free, and unscented options.
Answer Capsule
In November 2026, Cetaphil appeared in 56 of 368 AI answers included in the Sunscreen Brands benchmark (15.22%). It received 52 recommendations (14.13%), with 13 Top 3 placements and 1 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Cetaphil mentions, recommendations and placements compare with its Sunscreen Brands peers?
Cetaphil recorded 56 mentions (15.22%) and 52 recommendations (14.13%) across 368 answers included in the benchmark. Top 3 placements numbered 13; first-place recommendations numbered 1. Framing among its mentions was 52 positive, 4 neutral and 0 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | La Roche-Posay | 353 | 95.92% | 313 | 85.05% | 241 | 65.49% | 60 | 16.30% |
2 | EltaMD | 324 | 88.04% | 296 | 80.43% | 251 | 68.21% | 147 | 39.95% |
3 | Supergoop | 278 | 75.54% | 248 | 67.39% | 131 | 35.60% | 40 | 10.87% |
4 | Neutrogena | 274 | 74.46% | 232 | 63.04% | 99 | 26.90% | 21 | 5.71% |
5 | CeraVe | 262 | 71.20% | 230 | 62.50% | 119 | 32.34% | 25 | 6.79% |
6 | Sun Bum | 89 | 24.18% | 62 | 16.85% | 13 | 3.53% | 4 | 1.09% |
7 | Cetaphil | 56 | 15.22% | 52 | 14.13% | 13 | 3.53% | 1 | 0.27% |
8 | Kopari Beauty | 1 | 0.27% | 1 | 0.27% | 0 | 0.00% | 0 | 0.00% |
9 | Vichy | 3 | 0.82% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
Cetaphil appears in a modest share of benchmark answers, yet almost every appearance also carried a recommendation. That gap between reach and endorsement is the useful signal: when the brand shows up, the answers tend to speak well of it. The constraint is how often it enters the conversation at all, not how it is described when it does.
Position is the weaker dimension. Shortlist placements are limited and first-place finishes are rare, so Cetaphil is usually a supporting option rather than the lead suggestion. The agency would treat reach and position as separate goals, since improving how often the brand is named is a different task from earning the top slot.
What changed since last month
Questions This Section Answers
- How did Cetaphil counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 56 / 368 (15.22%) |
Recommendations | 52 / 368 (14.13%) |
Top 3 recommendations | 13 / 368 (3.53%) |
#1 recommendations | 1 / 368 (0.27%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first broad baseline, so the figures describe where Cetaphil stands rather than movement from a prior month. Earlier editions used a narrower question set and are not comparable. The agency would use this month as the reference point and judge future editions only against the same screening scope.
Because the sample is a selected set of answers rather than a continuous series, month-to-month differences should be read as separate observations. A later edition with a different answer total will not by itself explain any shift in counts or rates.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- Cetaphilno changeNov 202614.13%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Cetaphil?
AI answers contained 0 conflicting claims about Cetaphil: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
No conflicting claims about Cetaphil were recorded in the captured answers, so there is no immediate fact-check queue. That is a clean starting position, not a guarantee, and the agency would still build a scoped review register so any future claim has an owner and an evidence requirement before it is acted on.
A visibility comparison would sit alongside that register. Seeing where Cetaphil enters answers and where it is absent helps the client decide whether to invest in reach, in position, or in the pages that support both.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Cetaphil should be verified before proposed page edits?
No results are available for this part of the analysis.
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
No disputed topics were supplied for this part of the analysis, so there is nothing to verify or correct at present. The agency would not invent a conflict to fill the gap. Instead, it would keep the review register open and add items only when a specific claim, date and source can be checked against primary material.
If a claim does surface later, the first step is to confirm the entity and the date, since different product versions can look like a contradiction. Page briefs would follow only after that check, and only where the current page genuinely needs a change.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Cetaphil?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://amazon.com/Cetaphil-Redness-Relieving-Facial-Moisturizer/dp/B01M31HUYJ?psc=1&ref_=bing_fplfs&source=ps-sl-shoppingads-lpcontext | 1 | 1 | 0 |
https://cvs.com/shop/cetaphil-everyday-sunscreen-tinted-face-lotion-spf-40-1-7-oz-prodid-626694 | 1 | 1 | 0 |
https://heb.com/product-detail/cetaphil-daily-facial-moisturizer-spf-50-/1226452 | 1 | 1 | 0 |
https://target.com/p/cetaphil-daily-facial-moisturizer-broad-spectrum-spf-50-1-7-fl-oz/-/A-76153640 | 1 | 1 | 0 |
https://target.com/p/cetaphil-daily-facial-moisturizer-broad-spectrum-spf-50-1-7-fl-oz/-/A-76153640?TCID=OAG&afid=chatgpt | 1 | 1 | 0 |
https://allure.com/gallery/best-moisturizers-with-spf | 21 | 5 | 0 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages are mostly retailer listings for Cetaphil sunscreen and moisturizer products, plus one beauty gallery that accounts for most of the citation appearances. None of these pages is linked to a conflicting claim in the captured answers, so there is no correction case to pursue. The agency would review the pages for accuracy and freshness before considering any request.
Publisher outreach would be limited and evidence-backed. A citation does not show that a page shaped an answer, and the agency cannot assume control over retailer or editorial content. Requests would be framed as factual clarifications, with responses recorded separately from confirmed edits.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Cetaphil website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://cetaphil.com/us/products/product-categories/all-cleansers/cetaphil-gentle-skin-cleanser/302990110227.html | 1 | 0 | 0 |
https://cetaphil.com/us/products/product-categories/all-cleansers/dermacontrol-oil-removing-foam-wash/302993931188.html | 1 | 0 | 0 |
https://cetaphil.com/us/products/product-categories/facial-moisturizers | 1 | 0 | 0 |
https://cetaphil.com/us/skincare-tips/skincare-guides/best-face-wipes-if-you-have-sensitive-oily-or-dry-skin.html | 1 | 0 | 0 |
The company's website was cited 4 times across 4 distinct page addresses; the table shows 4 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
The company site was cited a handful of times across distinct pages, and none of those citations appeared in benchmark answers that recommended Cetaphil. That does not mean the pages are weak; it means the recorded answers did not draw on them in a recommending context. The agency would check current page content before proposing changes.
Page briefs would use approved product facts and the questions buyers actually ask, applied to the supplied page list. Cleanser and moisturizer pages would be assessed for whether they answer sunscreen-adjacent questions clearly, rather than rewritten on assumption.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Cetaphil?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What is the best moisturizer with SPF in it? | 2 | 2 | 2 |
What sunscreen doesn't have avobenzone? | 2 | 2 | 2 |
mineral face sunscreen | 2 | 2 | 2 |
Are there travel size sunscreens? | 1 | 1 | 1 |
Is there a non comedogenic sunscreen for acne? | 3 | 1 | 1 |
Is there a sunscreen that doesn't sting your eyes? | 1 | 1 | 1 |
Is there an unscented daily sunscreen? | 1 | 1 | 1 |
What brands are non-comedogenic? | 1 | 1 | 1 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions cluster around sunscreen choice for sensitive or acne-prone skin: non-comedogenic options, avobenzone-free formulas, mineral sunscreens, unscented daily wear and eye-friendly formulas. Cetaphil was mentioned and recommended in most of these observed answers, which suggests the brand already fits the conversation when the question is framed that way.
These are answer observations, not search volume. Before proposing new pages, the agency would check existing coverage and build briefs only where a genuine gap exists, using buyer language drawn from the recorded questions.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Cetaphil work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and review status. The second month turns approved findings into page briefs and any justified publisher requests, with confirmed edits and no-change decisions logged separately.
The final month produces buyer-question content briefs and a fresh scorecard. Completed work would be reported apart from measured answer outcomes, and no visibility gain would be promised; the benchmark describes what answers said, and any change in later answers would be observed rather than credited to this work.
Methodology
Questions This Section Answers
- How are Cetaphil answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 368 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5744 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 368 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The benchmark covers answers collected for this edition, though the exact collection dates are unverified. A company counts as recommended only when an answer endorses it with positive wording, and shortlist and first-place counts sit inside those recommendations rather than adding to them.
Answers can name several companies, so counts cannot be summed into distinct answers. Citation appearances across the wider capture differ from benchmark citations, and cited page contents still need independent checking.
Our first three priorities
The first priority is to keep the clean claim position clean. With no conflicting claims recorded, the agency would set up the review register now so future claims are checked against primary sources before anyone acts, and ambiguous matches stay out of the queue.
The second is to understand why Cetaphil enters so few answers despite being well received when it does. A visibility comparison against the leading brands would show which question types the brand is missing from, without assuming the cause.
The third is buyer-question content. The recorded questions point to sensitive-skin and non-comedogenic sunscreen topics where Cetaphil already appears; the agency would check existing pages first, then brief only where coverage is genuinely thin.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending Sunscreen Brands. For more detail, you can also read Sunscreen Brands: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


